Navigation Links
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
Date:2/19/2009

, and we will complete a confirmatory Phase III trial for Xibrom QD to support our sNDA filing. We also have initiated a clinical study with a lower concentration of Xibrom to treat dry eye syndrome. At the end of 2008, we completed a Phase IIb clinical study for ecabet sodium and believe the recently announced positive results, in addition to our previous Phase II studies, provide a clear path forward to the Phase III study designs and NDA filing requirements. Based upon our further analysis of the ecabet sodium Phase II data and results from our Xibrom lower concentration study, we will make a decision on which product or products in our dry eye franchise to move into Phase III trials, which could start as early as 2010."

Dr. Anido concluded, "We expect 2009 will be an exciting year for ISTA with a number of catalysts. FDA approval of Bepreve will take ISTA into the largest category in which we have competed, and we believe we will have the same type of success we had with Xibrom in the ophthalmic NSAID space. We also expect to be approximately breakeven on an operating income basis in 2009, reflecting our evolution from a drug development company to a successful, commercial pharmaceutical company. Although we anticipate a difficult macro environment in 2009, we believe we have the people and strategies to utilize our deep pipeline and strong financials for continued growth in the upcoming year."

                                      Net Revenue
                         (in millions, except percentage data)

                         Year-Ended             Year-Ended
                      December 31, 2008      December 31, 2007    % Change
    Xibrom                        $63.0                  $42.1         50%
    Istalol                        14.6                   11.3         29%
    Vitrase                         5.2                    5.2          0%
    Other                           0.3            
'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... (PRWEB) March 29, 2015 Youth Villages ... counties in Oregon to assess the feasibility of implementing ... emotional and behavioral problems and their families. , Third ... select participants that will be provided technical assistance throughout ... counties join six other national awardees chosen by Third ...
(Date:3/29/2015)... 2015 “Health is an endo thing, ... learn more about the cannabinoid system … we learn ... Publius’ Go Endo-Cannabinoid Update ~ new on the ... celebrated. Publius, of The Cannabis Papers: A citizen’s guide ... Health (PubMed) cannabinoid system (CS) articles discussing: cannabinoids in ...
(Date:3/28/2015)... March 28, 2015 Could genetic code ... new study by researchers at the Harvard ... with the support of the Coffee and Caffeine Genetics ... Psychiatry this past fall, the study—one of several recent ... genomic data from more than 120,000 regular coffee drinkers ...
(Date:3/28/2015)... 28, 2015 With more than ... fields of osteoporosis, osteoarthritis and musculoskeletal diseases gathered ... may be the first time in the 17-year ... that the hot-button topic is an emerging non-pharmaceutical ... well-accepted scientific principles of Wolff’s law, osteogenic loading ...
(Date:3/28/2015)... Emergency Medical Care (EMC), a New York ... commemorated its three-year anniversary of being the only 24/7 ... 24-hour urgent care, Emergency Medical Care offers its clients ... Emergency Medical Care’s Urgent Care NYC services ... injuries, ear infections, fevers, insect bites, burns, animal bites, ...
Breaking Medicine News(10 mins):Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4Health News:March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ New on the Bryan William Brickner Blog 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2
... with positive airway pressure (PAP) therapy improves a number ... from the The Children,s Hospital of Philadelphia. "In ... we observed significant improvements in neurobehavioral function after three ... Marcus, professor of pediatrics at the Children,s Hospital of ...
... , THURSDAY, Feb. 9 (HealthDay News) -- A growing ... plastic surgery from social networking sites rather than friends, ... in 2011 got information from social media such as Facebook ... in 2010. The number of patients who sought information from ...
... , THURSDAY, Feb. 9 (HealthDay News) -- Four new ... by researchers, who also pinpointed six independent diabetes-associated gene ... findings, from an analysis of 50,000 genetic variants across ... in the Feb. 9 issue of the American ...
... Wake Forest Baptist Medical Center researchers have again proven ... them with a quick, 30-second laser treatment can kill them. ... was published in 2009, but now they,ve taken the science ... initiating cancer stem cells. These stem cells are hard to ...
... This release is available in French . ... patients with advanced cancer suffer from cachexia, a condition ... weight loss, extreme fatigue and reduces quality of life. ... University Health Centre (MUHC) has found that patients with ...
... (HealthDay News) -- ,The longer Hispanic women live in the United ... a new study says. Researchers analyzed data from 2,141 Hispanic ... U.S. National Health and Nutrition Examination Survey 1999-2006. The study ... women who had lived in the United States for less than ...
Cached Medicine News:Health News:PAP therapy improves neurobehavioral outcomes in children with OSA 2Health News:More Patients Seek Plastic Surgery Advice From Facebook, Twitter 2Health News:4 New Genes Linked to Type 2 Diabetes 2Health News:Nanotube therapy takes aim at breast cancer stem cells 2Health News:Heavy lifting for cancer research 2
(Date:3/27/2015)... HOLLYWOOD, Calif. , March 27, 2015 ... of life of myeloma patients while working toward prevention ... Higgins (D-NY) for introducing a federal resolution (H. ... of March 2015 as "National Multiple Myeloma Awareness Month." ... living with myeloma worldwide, and more than 110,000 new ...
(Date:3/27/2015)... -- RnRMarketResearch.com adds "Visceral Pain - ... of 52 pages with latest updates, data and ... The report "Visceral Pain - Pipeline Review, H1 2015" ... Visceral Pain, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:3/26/2015)... HOUSTON , March 26, 2015  The ... of a study independently conducted by the Department ... Japan have been published. ... compared 5-fluorouracil hepatic arterial infusion as post-operative adjuvant ... colorectal metastasis of the liver. ...
Breaking Medicine Technology:The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4
... 21, 2011  Watson Pharmaceuticals, Inc. (NYSE: WPI ... Paul Bisaro, Watson,s President and Chief Executive Officer, will ... at the 2011 Piper Jaffray Health Care Conference on ... the New York Palace Hotel in New York. The ...
... Ultragenyx Pharmaceutical, Inc., a biotechnology company focused on ... today announced that Tom Kassberg has joined the ... be responsible for leading the company,s business development ... the human resources and legal affairs functions. Mr. ...
Cached Medicine Technology:Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team 2Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team 3Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: